72 related articles for article (PubMed ID: 9866886)
1. [Evaluation study of the opinions on the Di Bella multi-therapy (MDB) of tumor patients].
Di Filippo F; Serraino D; Tirelli U
Clin Ter; 1998; 149(4):261-5. PubMed ID: 9866886
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation study of the opinion on Di Bella's multimodal therapy of patients with tumors. 2].
Di Filippo F; Serraino D; Tirelli U
Clin Ter; 1999; 150(2):121-5. PubMed ID: 10396861
[TBL] [Abstract][Full Text] [Related]
3. [On De Bella's therapy].
Bonomo L
Recenti Prog Med; 1998 May; 89(5):226. PubMed ID: 9676126
[No Abstract] [Full Text] [Related]
4. Gigantic cutaneous lymphoma following Di Bella's therapy.
Bassan R; Reseghetti A; Cortelazzo S; Rossi A; Buelli M; Viero P; Barbui T
Haematologica; 2002 Apr; 87(4):EIM13. PubMed ID: 11940500
[No Abstract] [Full Text] [Related]
5. Evaluation of an unconventional cancer treatment (the Di Bella multitherapy): results of phase II trials in Italy. Italian Study Group for the Di Bella Multitherapy Trails.
Italian Study Group for the Di Bella Multitherapy Trials
BMJ; 1999 Jan; 318(7178):224-8. PubMed ID: 9915729
[TBL] [Abstract][Full Text] [Related]
6. Multicycle dose-intensive chemotherapy for women with high-risk primary breast cancer: results of International Breast Cancer Study Group Trial 15-95.
; Basser RL; O'Neill A; Martinelli G; Green MD; Peccatori F; Cinieri S; Coates AS; Gelber RD; Aebi S; Castiglione-Gertsch M; Viale G; Price KN; Goldhirsch A
J Clin Oncol; 2006 Jan; 24(3):370-8. PubMed ID: 16421418
[TBL] [Abstract][Full Text] [Related]
7. [Experimentation with Di Bella polychemotherapy in Tuscany].
Orlandini C; Amunni G; Conte PF; Francini G; Rossini GC; Vanni D;
Epidemiol Prev; 2000; 24(5):209-12. PubMed ID: 11189475
[TBL] [Abstract][Full Text] [Related]
8. Effects of media information on cancer patients' opinions, feelings, decision-making process and physician-patient communication.
Passalacqua R; Caminiti C; Salvagni S; Barni S; Beretta GD; Carlini P; Contu A; Di Costanzo F; Toscano L; Campione F
Cancer; 2004 Mar; 100(5):1077-84. PubMed ID: 14983505
[TBL] [Abstract][Full Text] [Related]
9. Medical therapy of advanced malignant epithelial tumours of the ovary.
Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
[TBL] [Abstract][Full Text] [Related]
10. [End of the Di Bella cancer therapy].
Ernst E
MMW Fortschr Med; 1999 Jun; 141(25):22-3. PubMed ID: 10897900
[No Abstract] [Full Text] [Related]
11. Preoperative combined modality therapy with paclitaxel, carboplatin, prolonged infusion 5-fluorouracil, and radiation therapy in localized esophageal cancer: preliminary results of a Minnie Pearl Cancer Research Network phase II trial.
Meluch AA; Hainsworth JD; Gray JR; Thomas M; Whitworth PL; Davis JL; Greco FA
Cancer J Sci Am; 1999; 5(2):84-91. PubMed ID: 10198730
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial.
Chen GY; Jiang GL; Wang LJ; Qian H; Fu XL; Yang H; Wu KL; Zhao S
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):70-5. PubMed ID: 15629596
[TBL] [Abstract][Full Text] [Related]
13. Patient willingness to undergo chemotherapy and thoracic radiotherapy for locally advanced non-small cell lung cancer.
Hirose T; Yamaoka T; Ohnishi T; Sugiyama T; Kusumoto S; Shirai T; Okuda K; Ohmori T; Adachi M
Psychooncology; 2009 May; 18(5):483-9. PubMed ID: 18942662
[TBL] [Abstract][Full Text] [Related]
14. Are increased tumor aneuploidy and heightened cell proliferation along with heterogeneity associated with patient outcome for carcinomas of the uterine cervix? A combined analysis of subjects treated in RTOG 9001 and a single-institution trial.
Wolfson AH; Winter K; Crook W; Krishan A; Grigsby PW; Markoe AM; Morris M; Gaffney DK; Eifel PJ; Lucci JA
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):111-7. PubMed ID: 17919835
[TBL] [Abstract][Full Text] [Related]
15. Phase III study of adjuvant chemotherapy and radiation therapy compared with chemotherapy alone in the surgical adjuvant treatment of colon cancer: results of intergroup protocol 0130.
Martenson JA; Willett CG; Sargent DJ; Mailliard JA; Donohue JH; Gunderson LL; Thomas CR; Fisher B; Benson AB; Myerson R; Goldberg RM
J Clin Oncol; 2004 Aug; 22(16):3277-83. PubMed ID: 15249584
[TBL] [Abstract][Full Text] [Related]
16. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of preoperative combined radiation therapy and chemotherapy with 5-fluorouracil and cisplatin in potentially resectable pancreatic adenocarcinoma: The French SFRO-FFCD 97-04 Phase II trial.
Mornex F; Girard N; Scoazec JY; Bossard N; Ychou M; Smith D; Seitz JF; Valette PJ; Roy P; Rouanet P; Ducreux M; Partensky C
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1471-8. PubMed ID: 16793214
[TBL] [Abstract][Full Text] [Related]
18. Whole-body hyperthermia in the scope of von Ardenne's systemic cancer multistep therapy (sCMT) combined with chemotherapy in patients with metastatic colorectal cancer: a phase I/II study.
Hildebrandt B; Dräger J; Kerner T; Deja M; Löffel J; Stroszczynski C; Ahlers O; Felix R; Riess H; Wust P
Int J Hyperthermia; 2004 May; 20(3):317-33. PubMed ID: 15204528
[TBL] [Abstract][Full Text] [Related]
19. Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer: a randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast Group.
Morales L; Canney P; Dyczka J; Rutgers E; Coleman R; Cufer T; Welnicka-Jaskiewicz M; Nortier J; Bogaerts J; Therasse P; Paridaens R; ;
Eur J Cancer; 2007 Jan; 43(2):331-40. PubMed ID: 17134892
[TBL] [Abstract][Full Text] [Related]
20. Phase I dose-escalation study of tezacitabine in combination with 5-fluorouracil in patients with advanced solid tumors.
Bendell JC; Eder JP; Clark JW; Fidias P; Lynch TJ; Seiden MV; Ryan DP
Cancer; 2005 May; 103(9):1925-31. PubMed ID: 15772958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]